| Primary |
| Drug Use For Unknown Indication |
29.9% |
| Hypertension |
19.4% |
| Anticoagulant Therapy |
9.0% |
| Blood Pressure |
6.0% |
| Atrial Fibrillation |
4.5% |
| Stent Placement |
4.5% |
| Blood Cholesterol Increased |
3.0% |
| Chronic Obstructive Pulmonary Disease |
3.0% |
| Heart Rate |
3.0% |
| Pregnancy |
3.0% |
| Angina Pectoris |
1.5% |
| Arrhythmia |
1.5% |
| Atrial Tachycardia |
1.5% |
| Depression |
1.5% |
| Diabetes Mellitus |
1.5% |
| Glaucoma |
1.5% |
| Hypercoagulation |
1.5% |
| Mitral Valve Prolapse |
1.5% |
| Palpitations |
1.5% |
| Product Used For Unknown Indication |
1.5% |
|
| Vertigo |
14.3% |
| Haemorrhage |
7.1% |
| Ill-defined Disorder |
7.1% |
| Palpitations |
7.1% |
| Visual Acuity Reduced |
7.1% |
| Vomiting |
7.1% |
| Angina Pectoris |
3.6% |
| Arrhythmia |
3.6% |
| Blood Pressure Abnormal |
3.6% |
| Colonic Pseudo-obstruction |
3.6% |
| Drug Exposure During Pregnancy |
3.6% |
| Dyspepsia |
3.6% |
| Dystonia |
3.6% |
| Epistaxis |
3.6% |
| Haematochezia |
3.6% |
| Hypertrichosis |
3.6% |
| Lip Swelling |
3.6% |
| Medication Error |
3.6% |
| Musculoskeletal Pain |
3.6% |
| No Adverse Event |
3.6% |
|
| Secondary |
| Hypertension |
21.5% |
| Drug Use For Unknown Indication |
16.1% |
| Product Used For Unknown Indication |
12.9% |
| Atrial Fibrillation |
7.5% |
| Arrhythmia |
3.8% |
| Arrhythmia Prophylaxis |
3.8% |
| Back Pain |
3.2% |
| Anxiety |
2.7% |
| Cerebrovascular Accident Prophylaxis |
2.7% |
| Drug Therapy |
2.7% |
| Migraine |
2.7% |
| Muscle Spasms |
2.7% |
| Pain |
2.7% |
| Prostatomegaly |
2.7% |
| Thrombosis Prophylaxis |
2.7% |
| Breakthrough Pain |
2.2% |
| Heart Rate Increased |
2.2% |
| Neuralgia |
2.2% |
| Blood Cholesterol Increased |
1.6% |
| Depression |
1.6% |
|
| Polyarthritis |
10.5% |
| Prostatomegaly |
10.5% |
| Tremor |
10.5% |
| Ventricular Hypokinesia |
10.5% |
| Erythema |
5.3% |
| Headache |
5.3% |
| Multi-organ Disorder |
5.3% |
| Pain |
5.3% |
| Stress |
5.3% |
| Thrombosis |
5.3% |
| Angina Pectoris |
2.6% |
| Anxiety |
2.6% |
| Asthenia |
2.6% |
| Atrial Fibrillation |
2.6% |
| Disorientation |
2.6% |
| Drug Ineffective |
2.6% |
| Dyspepsia |
2.6% |
| Erectile Dysfunction |
2.6% |
| Eyelid Oedema |
2.6% |
| Fall |
2.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
20.3% |
| Drug Use For Unknown Indication |
14.3% |
| Hypertension |
13.3% |
| Atrial Fibrillation |
7.5% |
| Diabetes Mellitus |
5.4% |
| Cardiac Disorder |
5.2% |
| Osteoporosis |
3.5% |
| Pain |
3.4% |
| Blood Cholesterol Increased |
3.2% |
| Asthma |
3.0% |
| Chronic Obstructive Pulmonary Disease |
2.9% |
| Rheumatoid Arthritis |
2.7% |
| Gastrooesophageal Reflux Disease |
2.6% |
| Arthritis |
2.5% |
| Depression |
2.4% |
| Prophylaxis |
1.8% |
| Anxiety |
1.7% |
| Type 2 Diabetes Mellitus |
1.6% |
| Hormone Replacement Therapy |
1.4% |
| Pulmonary Arterial Hypertension |
1.3% |
|
| Vomiting |
15.2% |
| Weight Increased |
10.8% |
| Weight Decreased |
7.2% |
| Dyspnoea |
6.3% |
| Nausea |
6.3% |
| Death |
4.9% |
| Vision Blurred |
4.9% |
| Drug Ineffective |
4.6% |
| Myocardial Infarction |
4.4% |
| Pain |
4.2% |
| Urinary Tract Infection |
4.2% |
| Tremor |
3.6% |
| Oedema Peripheral |
3.2% |
| Renal Failure |
3.2% |
| Pneumonia |
3.0% |
| Pain In Extremity |
2.9% |
| Syncope |
2.9% |
| Type 2 Diabetes Mellitus |
2.9% |
| Fatigue |
2.7% |
| Insomnia |
2.7% |
|
| Interacting |
| Drug Use For Unknown Indication |
73.3% |
| Bronchopulmonary Aspergillosis Allergic |
6.7% |
| Arterial Occlusive Disease |
3.3% |
| Arterial Spasm |
3.3% |
| Blood Cholesterol Increased |
3.3% |
| Blood Triglycerides Increased |
3.3% |
| Cardiac Disorder |
3.3% |
| Hypertension |
3.3% |
|
| Tachycardia |
50.0% |
| Inhibitory Drug Interaction |
25.0% |
| Urticaria |
25.0% |
|
